Rare diseases, despite being individually rare, cumulatively affect millions of people around the world. Over the last decades, high throughput sequencing elevated diagnostic success in rare diseases from ~10% to ~45% but have stalled at ~45% since. One reason for that may be that clinical presentation of the disease-causing alteration(s) could be highly variable. Some […]
Read More